PLYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Polaryx Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.92+0.04 (+2.13%)
Close on Oct 19, 2026
- Market cap
- $92.69M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Polaryx Therapeutics has not reported a dividend
No dividend per share appears in Polaryx Therapeutics's annual filings since fiscal 2023.